Mesothelioma trials in China

In China 15 Also abroad 104

15 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fujian, Guangdong, Hangzhou, Henan, Hubei, Nanchang, Shanghai, Shanxi, Shengyang, Tianjin
Age
18 years and over
People
952 worldwide
Run by
Genmab
See details and how to joinNCT05579366
Phase 1/2Taking people
Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma
Where
Chengdu, Shanghai
Age
18 years to 75 years
People
78
Run by
Ruijin Hospital
See details and how to joinNCT07885319
Phase 2Not yet taking people in China
First-line Treatment With Dual Immunotherapy Combined With Anti-angiogenesis for Unresectable Advanced Malignant Peritoneal Mesothelioma
Where
Shanghai
Age
18 years and over
People
19
Run by
Fudan University
See details and how to joinNCT07893340
Phase 1/2Taking people
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Where
Beijing, Guangzhou, Shanghai, Zhengzhou
Age
18 years and over
People
160 worldwide
Run by
InSilico Medicine Hong Kong Limited
See details and how to joinNCT06566079
Phase 2Taking people
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Where
Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jining, Kunming, Nanchang, Nanjing, Nanning, Shandong, Shanghai, Shenyang, Tianjin, Wuhan, Wuhou District, Zhengzhou
Age
18 years to 64 years
People
257 worldwide
Run by
AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00
Phase 1Taking people
APG-2449 in Patients With Advanced Solid Tumors
Where
Beijing, Changsha, Fuzhou, Guangzhou, Hangzhou, Wuhan, Zhengzhou
Age
18 years and over
People
165
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT03917043
No phaseTaking people
PTC-Guided Therapy for Peritoneal Mesothelioma
Where
Beijing
Age
18 years to 85 years
People
347
Run by
Beijing Tsinghua Chang Gung Hospital
See details and how to joinNCT07330271
Phase 2Not yet taking people in China
Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma
Where
Shanghai
Age
18 years to 75 years
People
37
Run by
Fudan University
See details and how to joinNCT07514793
Phase 1/2Taking people
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Where
Shenzhen
Age
18 years to 75 years
People
36
Run by
Beijing Biotech
See details and how to joinNCT07510815
Phase 1/2Not yet taking people in China
Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors
Where
Shanghai
Age
18 years and over
People
219
Run by
TYK Medicines, Inc
See details and how to joinNCT07282873
Phase 2Taking people
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
Where
Beijing, Taiyuan
Age
18 years and over
People
29
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05188859
Phase 2Taking people
Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma
Where
Changchun
Age
18 months to 75 months
People
25
Run by
The First Hospital of Jilin University
See details and how to joinNCT06875076
Phase 1Taking people
A Study of MT027 in Patients with Pleural Malignant Tumors
Where
Beijing
Age
18 years and over
People
18
Run by
Suzhou Maximum Bio-tech Co., Ltd.
See details and how to joinNCT06726564
Phase 2Taking people
Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
Where
Beijing
Age
18 years and over
People
28
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06543069
Phase 1Taking people
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
Where
Guangzhou
Age
18 years to 75 years
People
30
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06196294